[Hemotherapy with an antithrombin-antiplasmin concentrate of human plasma (alpha2-macroglobulin concentrate)].
D000510:Alpha-Globulins / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D000991:Antithrombins / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D001780:Blood Coagulation Tests; D005342:Fibrinolysis; D006801:Humans; D008259:Macroglobulins / Q000627:therapeutic use*; D013917:Thrombin / Q000032:analysis; D013925:Thromboplastin / Q000032:analysis
D000510:Alpha-Globulins; D000933:Antifibrinolytic Agents; D000991:Antithrombins; D008259:Macroglobulins; D013925:Thromboplastin; D013917:Thrombin
Zur Hämotherapie mit einem Antithrombin-Antiplasmin-Konzentrat aus Humanplasma (alpha2-Makroglobulin-Konzentrat)